COVID-19: Current landscape on global incidence of neurologic features and their restorative strategies
1 University Institute of Pharmacy, Pt. Ravishankar Shukla University Raipur, Chhattisgarh, India.
2 Colombia College of pharmacy, Raipur Chhattisgarh, India.
Review Article
GSC Biological and Pharmaceutical Sciences, 2022, 21(01), 197–207.
Article DOI: 10.30574/gscbps.2022.21.1.0402
Publication history:
Received on 15 September 2022; revised on 18 October 2022; accepted on 21 October 2022
Abstract:
According to WHO, he SARS-CoV-2 Coronavirus malady to begin with showed up in Wuhan, China in December 2019 and rapidly spread to more than 200 nations, coming about in a worldwide wellbeing widespread. There are over 3.5 million affirmed cases and between 165,000 and 243,000 fatalities. The essential signs are respiratory and cardiac, but neurological highlights have too been detailed in case reports and case arrangement with in the writing. Headache and tipsiness are the ore most detailed side effects, taken after by encephalopathy and daze cerebrovascular mischance, Guillian barre disorder, intense transverse myelitis, and intense encephalitis are among the complications famous. Hyposmia was the foremost common fringe appearance. It ought to moreover be famous that neurological appearances can in some cases go before normal highlights such as fever and hack, and those normal signs create afterward in these patients. Our objective is to advise neurologists and doctors who are treating suspected COVID19cases around the conceivable neurological introductions, plausible neurological complications, and the different treatment options available, to consider the long run of this worldwide widespread, and to distinguish a few potential alternatives that may revolutionize the treatment of this novel infection disease. We provide an outline of the current information concerning neurological appearances related with COVID-19, to the extent that literature is already available as the pandemic is still progressing.
Keywords:
COVID – 19; Encephalopathy; Hyposmia; Guillian barre syndrome; Neurological
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
